Zobrazeno 1 - 10 of 6 920 pro vyhledávání: '"REGORAFENIB"'
1
Akademický článek
CircDCAF8 promotes the progression of hepatocellular carcinoma through miR-217/NAP1L1 Axis, and induces angiogenesis and regorafenib resistance via exosome-mediated transfer.
Autor: Gong, Jiahao1,2 (AUTHOR), Han, Guoyong1,2 (AUTHOR), Chen, Zhiqiang1,2 (AUTHOR), Zhang, Yinqi1,2 (AUTHOR), Xu, Bin3 (AUTHOR), Xu, Chao1,2 (AUTHOR), Gao, Wen4 (AUTHOR) gaowen@jsph.org.cn, Wu, Jindao1,2 (AUTHOR) wujindao@njmu.edu.cn
Publikováno v: Journal of Translational Medicine. 5/30/2024, Vol. 22, p1-20. 20p.
Zobrazit plný text záznamu
2
Akademický článek
Regorafenib with immunotherapy versus regorafenib alone as second‐line treatment for hepatocellular carcinoma: A multicenter real‐world study.
Autor: Qiao, Liang1,2 (AUTHOR), He, Wei1,2 (AUTHOR), Wang, Guoying3,4 (AUTHOR), Chen, Huanwei5 (AUTHOR), Huang, Fuxi6 (AUTHOR), Zhang, Bo7 (AUTHOR), Qiu, Yuxiong1,2 (AUTHOR), Liu, Shaoru1,2 (AUTHOR), Huang, Zhenkun1,2 (AUTHOR), Yuan, Yichuan1,2 (AUTHOR), Qiu, Jiliang1,2 (AUTHOR), Yuan, Yunfei1,2 (AUTHOR) yuanyf@mail.sysu.edu.cn, Li, Binkui1,2 (AUTHOR) libk@sysucc.org.cn
Publikováno v: Cancer Medicine. May2024, Vol. 13 Issue 9, p1-13. 13p.
Zobrazit plný text záznamu
3
Akademický článek
Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling.
Autor: Morelli, Mariangela1 (AUTHOR) f.lessi@fpscience.it, Lessi, Francesca1 (AUTHOR) s.franceschi@fpscience.it, Franceschi, Sara1 (AUTHOR) m.giacomarra@fpscience.it, Ferri, Gianmarco1 (AUTHOR) c.mazzanti@fpscience.it, Giacomarra, Manuel1 (AUTHOR), Menicagli, Michele1 (AUTHOR), Gambacciani, Carlo2 (AUTHOR) orazio.santonocito@uslnordovest.toscana.it, Pieri, Francesco2 (AUTHOR), Pasqualetti, Francesco3 (AUTHOR), Montemurro, Nicola4 (AUTHOR) nicola.montemurro@unipi.it, Aretini, Paolo1 (AUTHOR), Santonocito, Orazio Santo2 (AUTHOR), Di Stefano, Anna Luisa2 (AUTHOR), Mazzanti, Chiara Maria1 (AUTHOR)
Publikováno v: Cells (2073-4409). Mar2024, Vol. 13 Issue 6, p487. 19p.
Zobrazit plný text záznamu
4
Akademický článek
Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning.
Autor: Ran, Pan1 (AUTHOR), Tan, Tao1 (AUTHOR), Li, Jinjin1 (AUTHOR), Yang, Hao2 (AUTHOR), Li, Juan3 (AUTHOR) zpfirst@sina.com, Zhang, Jun1 (AUTHOR) zjun2323@sina.cn
Publikováno v: BMC Cancer. 2/24/2024, Vol. 24 Issue 1, p1-14. 14p.
Zobrazit plný text záznamu
5
Akademický článek
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer.
Autor: Taşçı, Elif Şenocak1 (AUTHOR) esenocak@gmail.com, Oyan, Başak2 (AUTHOR), Sönmez, Özlem2 (AUTHOR), Mutlu, Arda Ulaş2 (AUTHOR), Atcı, Muhammed Mustafa3 (AUTHOR), Sakin, Abdullah4 (AUTHOR), Öner, İrem5 (AUTHOR), Çınkır, Havva Yeşil6 (AUTHOR), Eryılmaz, Melek Karakurt7 (AUTHOR), Çağlayan, Dilek7 (AUTHOR), Balçık, Onur Yazdan8 (AUTHOR), Paksoy, Nail9 (AUTHOR), Karabulut, Senem10 (AUTHOR), Salim, Derya Kıvrak11 (AUTHOR), Bilir, Cemil12 (AUTHOR), Özen, Miraç13 (AUTHOR), Özçelik, Melike14 (AUTHOR), Arıcan, Ali2 (AUTHOR), Akagündüz, Baran15 (AUTHOR), İnal, Ali16 (AUTHOR)
Publikováno v: BMC Cancer. 1/22/2024, Vol. 24 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
6
Akademický článek
Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Autor: Xu, Huilin1 (AUTHOR) xhlcdd@163.com, Cao, Dedong2 (AUTHOR), Zhou, Dingjie2 (AUTHOR), Zhao, Nan2 (AUTHOR), Tang, Xixian2 (AUTHOR), Shelat, Vishalkumar G.3 (AUTHOR), Samant, Hrishikesh4 (AUTHOR), Satapathy, Sanjaya K.5 (AUTHOR), Tustumi, Francisco6 (AUTHOR), Aprile, Giuseppe7 (AUTHOR), He, Anbing1 (AUTHOR), Xu, Ximing2 (AUTHOR), Ge, Wei8 (AUTHOR)
Publikováno v: BMC Cancer. 10/19/2023, Vol. 23 Issue 1, p1-10. 10p.
Zobrazit plný text záznamu
7
Akademický článek
Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study.
Autor: Xu, Yongkang (AUTHOR), Fu, Shumin (AUTHOR), Liu, Kan (AUTHOR), Mao, Ye (AUTHOR), Wu, Jianbing (AUTHOR)
Publikováno v: Therapeutics & Clinical Risk Management. Oct2023, Vol. 19, p853-863. 11p.
Zobrazit plný text záznamu
8
Akademický článek
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Autor: Martin-Broto, Javier1,2,3 (AUTHOR) jmartin@atbsarc.org, Valverde, Claudia4 (AUTHOR), Hindi, Nadia1,2,3 (AUTHOR), Vincenzi, Bruno5 (AUTHOR), Martinez-Trufero, Javier6 (AUTHOR), Grignani, Giovanni7 (AUTHOR), Italiano, Antoine8 (AUTHOR), Lavernia, Javier9 (AUTHOR), Vallejo, Ana10 (AUTHOR), Tos, Paolo Dei11 (AUTHOR), Le Loarer, Francois12 (AUTHOR), Gonzalez-Campora, Ricardo13 (AUTHOR), Ramos, Rafael14 (AUTHOR), Hernández-Jover, Diana15 (AUTHOR), Gutierrez, Antonio16 (AUTHOR), Serrano, Cesar4 (AUTHOR), Monteagudo, Maria17 (AUTHOR), Letón, Rocio17 (AUTHOR), Robledo, Mercedes17,18 (AUTHOR), Moura, David S.1 (AUTHOR)
Publikováno v: Molecular Cancer. 8/9/2023, Vol. 22 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu
9
Akademický článek
Early low blood MALT1 expression levels forecast better efficacy of PD-1 inhibitor-based treatment in patients with metastatic colorectal cancer.
Autor: CHUANMING LI1, FAN YU1, WANLI XU2 xinci7160204@163.com
Publikováno v: Oncology Letters. Aug2023, Vol. 26 Issue 2, p1-11. 11p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje